ClinicalTrialsFinder
RecruitingNCT07717437

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Sponsor

Maastricht University Medical Center

Enrollment

350 participants

Start Date

Mar 16, 2021

Study Type

OBSERVATIONAL

Conditions

Liver CancerLiver Metastases

Summary

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with liver cancer and liver metastases. The study is currently recruiting participants at 31 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(31)

Rush University Medical Center

Chicago, Illinois, United States

Mayo Clinic

Rochester, Minnesota, United States

Cleveland Clinic

Cleveland, Ohio, United States

Monash Medical Centre

Clayton, Victoria, Australia

MedUni Wien

Vienna, State of Vienna, Austria

Social Center South (Klinik Favoriten)

Vienna, State of Vienna, Austria

UZ Antwerpen

Edegem, Antwerpen, Belgium

Erasmus Hospital

Anderlecht, Brussels Capital, Belgium

CHU de Liège

Liège, Liège, Belgium

UZ Gent

Ghent, Oost-Vlaanderen, Belgium

Juravinski Hospital and Cancer Centre

Hamilton, Ontario, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

McGill University Health Centre

Montreal, Quebec, Canada

University Hospital Aachen (Uniklinik RWTH Aachen)

Aachen, North Rhine-Westphalia, Germany

Klinikum Saarbrücken

Saarbrücken, Saarland, Germany

Universitätsklinikum Halle

Halle, Saxony-Anhalt, Germany

MUMC+

Maastricht, Limburg, Netherlands

Amsterdam UMC

Amsterdam, North Holland, Netherlands

Universitair Medisch Centrum Groningen

Groningen, Provincie Groningen, Netherlands

Leids Universitair Medisch Centrum

Leiden, South Holland, Netherlands

Erasmus MC

Rotterdam, South Holland, Netherlands

Auckland City Hospital

Grafton, Auckland, New Zealand

Oslo University Hospital

Oslo, Oslo, Norway

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, Spain

Vall d'Hebron University Hospital

Barcelona, Barcelona, Spain

Karolinska University Hospital

Stockholm, Stockholm County, Sweden

University Hospital Linköping

Linköping, Östergötland County, Sweden

Klinik Hirslanden

Zurich, Canton of Zurich, Switzerland

Aintree University Hospital

Liverpool, Merseyside, United Kingdom

Newcastle upon Tyne Hospitals

Newcastle upon Tyne, North East England, United Kingdom

Queen Elizabeth Hospital

Birmingham, West Midlands, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07717437

Related Trials

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

NCT072819241 location

DESTINY-PANTUMOUR04

NCT0712400018 locations

Collection of Blood From Patients With Cancer

NCT000342161 location

Jump: MR Simulation For Radiation Therapy Master Protocol

NCT045459572 locations

Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence?

NCT054921361 location